JP2014511929A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511929A5
JP2014511929A5 JP2014504429A JP2014504429A JP2014511929A5 JP 2014511929 A5 JP2014511929 A5 JP 2014511929A5 JP 2014504429 A JP2014504429 A JP 2014504429A JP 2014504429 A JP2014504429 A JP 2014504429A JP 2014511929 A5 JP2014511929 A5 JP 2014511929A5
Authority
JP
Japan
Prior art keywords
polysaccharide
formula
iii
bond
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014504429A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014511929A (ja
JP6122418B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2012/051768 external-priority patent/WO2012140580A1/en
Publication of JP2014511929A publication Critical patent/JP2014511929A/ja
Publication of JP2014511929A5 publication Critical patent/JP2014511929A5/ja
Application granted granted Critical
Publication of JP6122418B2 publication Critical patent/JP6122418B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014504429A 2011-04-11 2012-04-11 アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用 Active JP6122418B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1153116 2011-04-11
FR1153116 2011-04-11
PCT/IB2012/051768 WO2012140580A1 (en) 2011-04-11 2012-04-11 Polysaccharides comprising two antithrombin iii-binding sites, preparation thereof and use thereof as antithrombotic medicaments

Publications (3)

Publication Number Publication Date
JP2014511929A JP2014511929A (ja) 2014-05-19
JP2014511929A5 true JP2014511929A5 (enExample) 2015-04-02
JP6122418B2 JP6122418B2 (ja) 2017-04-26

Family

ID=46025830

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014504429A Active JP6122418B2 (ja) 2011-04-11 2012-04-11 アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用

Country Status (7)

Country Link
US (2) US9346894B2 (enExample)
EP (1) EP2697265B1 (enExample)
JP (1) JP6122418B2 (enExample)
AR (1) AR085961A1 (enExample)
TW (1) TW201247209A (enExample)
UY (1) UY34012A (enExample)
WO (1) WO2012140580A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2818871A1 (en) * 2013-06-28 2014-12-31 Roche Diagniostics GmbH Means and methods for universal calibration of anti-Factor Xa tests
CN103743837B (zh) * 2013-12-24 2015-01-21 山东泰邦生物制品有限公司 人抗凝血酶ⅲ肝素结合比例检测方法
KR102240937B1 (ko) * 2014-10-10 2021-04-15 삼성디스플레이 주식회사 표시 장치
US20170317516A1 (en) * 2014-11-06 2017-11-02 Mantisvision Ltd. Circuit to provide energy pulses
EP3398971A4 (en) * 2015-12-30 2019-09-25 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. SULFATED HEPARINOLIGOSACCHARIDE AND MANUFACTURING METHOD AND APPLICATION THEREOF
CN111175415A (zh) * 2019-12-24 2020-05-19 湖北亿诺瑞生物制药有限公司 一种依诺肝素钠中苄索氯铵残留的测定方法
CA3237396A1 (en) 2021-08-08 2023-02-16 University Of Rochester Nanomembrane device and method for biomarker sampling

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663639B1 (fr) 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2845686B1 (fr) 2002-10-10 2013-08-30 Aventis Pharma Sa Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
FR2889078B1 (fr) 2005-07-27 2007-11-02 Aventis Pharma Sa Nouvelle methode de chromatographie d'affinite d'antithrombine iii

Similar Documents

Publication Publication Date Title
RU2617764C2 (ru) Неантикоагулянтные гликозаминогликаны, содержащие повторяющиеся дисахаридные звенья, и их медицинское применение
JP2009538386A5 (enExample)
SI2794667T1 (en) Low anticoagulant heparins
HN2003000312A (es) Mezclas de polisacaridos derivados de heparina, supreparacion y las composiciones farmaceuticas que las contienen
Liu et al. Pharmacological effects and clinical applications of ultra low molecular weight heparins
JP6122418B2 (ja) アンチトロンビンｉｉｉ結合部位を２個含む多糖、これの調製および抗血栓薬剤としてのこれの使用
JP2008525311A5 (enExample)
US8518909B2 (en) Sulfated heptasaccharide and its use as an antithrombotic agent
US20120108544A1 (en) Acylated decasaccharides and their use as antithrombotic agents
CN107011456B (zh) 一种绿藻多糖及其制备方法
US20120115809A1 (en) Use of an acylated octasaccharide as an antithrombotic agent
US20110178039A1 (en) Oligosaccharide mixtures derived from heparin, preparation thereof and pharmaceutical compositions containing them
JPH07503496A (ja) 硫酸化多糖類，それらの調製法，医薬組成物および使用
US20120108542A1 (en) Sulfated octasaccharide and its use as antithrombotic agent
JP4897991B2 (ja) 超低分子量ヘパリン組成物
PT1651677E (pt) Misturas de oligossacarídeos derivados de heparina, sua preparação e as composições farmacêuticas que os contêm
FI3683242T3 (fi) Pentosaanipolysulfaatti ja menetelmä pentosaanipolysulfaatin valmistamiseksi
CN117304367B (zh) 岩藻糖化硫酸软骨素寡糖的衍生物及其制备方法与应用
JP6298052B2 (ja) 低分子量および超低分子量ヘパリンの製造方法
US8501711B2 (en) Acylated 1,6-anhydro decasaccharide and its use as an antithrombotic agent
JP2000080102A (ja) Ｏ−過硫酸化グリコサミノグリカン及びそれを有効成分として含有する抗血液凝固剤
JP2020066638A (ja) ヘパリンの会合体